Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="GARCON, N*" or (type exact bookEditor and editor="GARCON, N*")

Add to list
- Journal Article
- A1
- open access
Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans

Wivine Burny, Andrea Callegaro, Viviane Bechtold, Frédéric Clement (UGent) , Sophie Delhaye, Laurence Fissette, Michel Janssens, Geert Leroux-Roels (UGent) , Arnaud Marchant, Robert A. van den Berg, et al.

(2017) FRONTIERS IN IMMUNOLOGY. 8. p.14-30
Add to list
- Journal Article
- A1
- open access
Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Margherita Coccia, Catherine Collignon, Caroline Hervé, Aurélie Chalon, Iain Welsby, Sophie Detienne, Mary van Helden (UGent) , Sheetij Dutta, Christopher J Genito, Norman C Waters, et al.

(2017) NPJ VACCINES. 2(1).
Add to list
- Journal Article
- A1
- open access
Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine : results from a phase II, randomized, multicenter trial

Geert Leroux-Roels (UGent) , Arnaud Marchant, Jack Levy, Pierre Van Damme, Tino F Schwarz, Yves Horsmans, Wolfgang Jilg, Peter G Kremsner, Edwige Haelterman, Frédéric Clement (UGent) , et al.

(2016) CLINICAL IMMUNOLOGY. 169. p.16-27
Add to list
- Journal Article
- A1
- open access
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

Geert Leroux-Roels (UGent) , Pascale Van Belle, Pierre Vandepapeliere, Yves Horsmans, Michel Janssens, Isabelle Carletti, Nathalie Garçon, Martine Wettendorff and Marcelle Van Mechelen

(2015) VACCINE. 33(8). p.1084-1091
Add to list
Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Arnaud M Didierlaurent, Catherine Collignon, Patricia Bourguignon, Sandrine Wouters, Kaat Fierens (UGent) , Michel Fochesato, Najoua Dendouga, Christelle Langlet, Bernard Malissen, Bart Lambrecht (UGent) , et al.

(2014) JOURNAL OF IMMUNOLOGY. 193(4). p.1920-1930
Add to list
Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Pierre Vandepapeliere, Yves Horsmans, Philippe Moris, Marcelle Van Mechelen, Michel Janssens, Marguerite Koutsoukos, Pascale Van Belle, Frédéric Clement (UGent) , Emmanuel Hanon, Martine Wettendorff, et al.

(2008) VACCINE. 26(10). p.1375-1386
Add to list
- Journal Article
- A1
Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

P VANDEPAPELIERE, B REHERMANN, M KOUTSOUKOS, P MORIS, N GARCON, M WETTENDORFF and Geert Leroux-Roels (UGent)

(2005) VACCINE. 23(20). p.2591-2601
Add to list
- Journal Article
- A1
A hepatitis B vaccine formulated with a novel adjuvant system.

F AMBROSCH, G WIEDERMANN, M KUNDI, Geert Leroux-Roels (UGent) , Isabelle Desombere (UGent) , N GARCON, C THIRIART, M SLAOUI and S THOELEN

(2000) VACCINE. 18(20). p.2095-2101

Academic Bibliography

Different adjuvants induce common innate pathways that are associated with enhanced adaptive responses against a model antigen in humans

Cellular and molecular synergy in AS01-adjuvanted vaccines results in an early IFNγ response promoting vaccine immunogenicity

Impact of adjuvants on CD4+ T cell and B cell responses to a protein antigen vaccine : results from a phase II, randomized, multicenter trial

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS-21 induce strong humoral and cellular immune responses against hepatitis B surface antigen which persist for at least 4 years after vaccination

Enhancement of adaptive immunity by the human vaccine adjuvant AS01 depends on activated dendritic cells

Vaccine Adjuvant Systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers

Potent enhancement of cellular and humoral immune responses against recombinant hepatitis B antigens using AS02A adjuvant in healthy adults

A hepatitis B vaccine formulated with a novel adjuvant system.

Contents

Support

Contact